B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Total Liabilities & Equity Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Total Liabilities & Equity
kr218.5m
CAGR 3-Years
-28%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Liabilities & Equity
kr385.5m
CAGR 3-Years
-6%
CAGR 5-Years
11%
CAGR 10-Years
5%
L
Lytix Biopharma AS
OSE:LYTIX
Total Liabilities & Equity
kr63.9m
CAGR 3-Years
25%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Liabilities & Equity
kr339m
CAGR 3-Years
11%
CAGR 5-Years
36%
CAGR 10-Years
11%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Liabilities & Equity
$179.9m
CAGR 3-Years
-5%
CAGR 5-Years
36%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Liabilities & Equity
kr320.1m
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
18%

See Also

What is Bergenbio ASA's Total Liabilities & Equity?
Total Liabilities & Equity
218.5m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Total Liabilities & Equity amounts to 218.5m NOK.

What is Bergenbio ASA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-9%

Over the last year, the Total Liabilities & Equity growth was -9%. The average annual Total Liabilities & Equity growth rates for Bergenbio ASA have been -28% over the past three years , -9% over the past five years .

Back to Top